Results 101 to 110 of about 528,622 (127)

Efficacy of CytoSorb® - A Metaanalysis

open access: yes, 2022
Becker S   +5 more
europepmc   +1 more source

Does CytoSorb Interfere with Immunosuppression? A Pharmacokinetic and Functional Evaluation

open access: yes
Background/Objectives: Cytokine release during organ transplantation contributes to primary graft dysfunction and requires careful immunomodulation. CytoSorb, a hemoadsorption device developed to reduce circulating cytokine levels, is increasingly used ...
Claudia Schildböck   +4 more
core   +1 more source

ç©æ¥­ç®¡çå¬å¸æåå®å¹æ¨¡å¼ä¹å»ºç«

open access: yes, 2014
æåä¹ç©æ¥­ç®¡ç(Property Management, PM)å¬å¸ä¹ç¢åï¼ç©ç®¡æåçå質è广 ¼çºå½±é¿ç©ç®¡å¬å¸ç¶ç績æä¹ééµã檢è¦ç¾ä»ç©æ¥­ç®¡çç¢æ¥­ä¹æ¦æ³ï¼ç±æ¼åå°åå§æ³ä»¤ä¸å¥å¨åé²å¥é檻è¼ä½ä¹å½±é¿ï¼ä»¥è³æ¼ç©æ¥­ç®¡ç業èèæ¼ååç«¶ç­çç°å¢ï¼é²èé ææ¥­èéç«¶ç­åå¹å½±é¿å¶å質è婿½¤ãçºæ­¤ï¼åå ...
è¡æä¿®
core  

Hemoperfusion with CytoSorb® in Critically Ill COVID-19 Patients. [PDF]

open access: yesBlood Purif, 2022
Peng JY   +5 more
europepmc   +1 more source

Effects of CytoSorb<sup>®</sup> hemoadsorption therapy on serum myoglobin and creatine kinase levels in severe rhabdomyolysis: a systematic review and meta-analysis. [PDF]

open access: yesBMC Nephrol
Reynolds A   +14 more
europepmc   +1 more source

Hemadsorption with CytoSorb in Infants with Sepsis: Non-Systematic Review of Cases

open access: yes
Sepsis is a severe and potentially life-threatening condition that occurs when the body’s response to an infection damages its own tissues and organs. It can lead to organ failure and death if not treated. Cytosorb is a promising medical device for
Vitaliy Sazonov, Aruzhan Borankulova
core   +1 more source

Hemoadsorption Using CytoSorb® in Patients with Infective Endocarditis: A German-Based Budget Impact Analysis. [PDF]

open access: yesJ Cardiovasc Dev Dis, 2023
Rao C   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy